secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001104659-22-127475
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hepion shareholders approve reverse stock split; Board to set ratio 1:2 to 1:20
-------------------------------------------------------------------------------

- Special meeting held Dec 15, 2022; proposal to amend charter for reverse split approved.
- Vote: 6,757,528,739 for, 3,262,017,173 against, 38,856,945 abstained; 0 broker non-votes.
- Board authorized to select ratio between 1:2 and 1:20 within one year of meeting.
- Proposal covers all outstanding common and preferred shares as of Nov 8, 2022 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/0001104659-22-127475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/tm2232810d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-127475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer